- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rituxan® (rituximab)
Total 16885 results
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Jean M. Tersak, M.D.Genentech, Inc.TerminatedNeuroblastoma | Opsoclonus-myoclonus
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly
-
Hoffmann-La RocheCompletedA Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance
-
Hoffmann-La RocheCompleted
-
Georg Hess, MDRoche Pharma AG; Klinikum Frankfurt HöchstCompletedRelapsed Non-Hodgkin-Lymphoma
-
National Institute of Neurological Disorders and...Completed
-
BiogenTerminatedNon-Hodgkin's LymphomaUnited States
-
AmgenCompletedLymphoma, Non-HodgkinItaly, Spain, United States, Korea, Republic of, Australia, Georgia, Canada, Japan, Bulgaria, India, Romania, Colombia, Mexico, Czechia, France, Germany, Greece, Israel, Poland, Ukraine
-
CelltrionCompleted
-
Gilead SciencesApproved for marketingChronic Lymphocytic Leukemia (CLL)United States, Italy, United Kingdom, Ireland
-
Gilead SciencesThe Leukemia and Lymphoma SocietyActive, not recruitingNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Jurgen BarthSponsor GmbHActive, not recruitingNon-Hodgkin's Lymphoma | Lymphocytic Lymphoma | Marginal Zone Lymphomas | Follicular Lymphomas | Immunocytomas | Mantle-Cell LymphomasGermany
-
Hoffmann-La RocheCompleted
-
Johns Hopkins UniversityTerminatedKidney FailureUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaGermany
-
M.D. Anderson Cancer CenterCompletedIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompleted
-
SecuraBioTerminatedCD20+ Follicular LymphomaBelgium, Italy, United States, Spain, United Kingdom, France
-
Masonic Cancer Center, University of MinnesotaMillennium Pharmaceuticals, Inc.TerminatedLymphoproliferative DisorderUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and... and other collaboratorsCompletedEpstein Barr Virus Infections | Post-transplant Lymphoproliferative Disease | Solid Organ Transplant | Stem Cell Transplant (Bone Marrow Transplant)United States
-
Hoffmann-La RocheCompleted
-
ZymoGeneticsCompletedLymphoma, Non-HodgkinUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-cell Lymphoma | Rituximab | ToripalimabChina
-
Hoffmann-La RocheCompletedRheumatoid ArthritisBelgium, France, Germany, Spain, United Kingdom, Australia, Canada, Taiwan, Thailand, China, Hungary, Italy, Netherlands, South Africa, Slovakia, Finland, New Zealand, Brazil
-
Pharmacyclics LLC.CompletedFollicular Lymphoma | B-cell Lymphoma | Non-Hodgkin's LymphomaUnited States
-
University of California, San DiegoGenentech, Inc.CompletedRheumatoid ArthritisUnited States
-
Hospital Universitario Dr. Jose E. GonzalezCompletedGraft vs Host DiseaseMexico
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedNon-Hodgkin's Lymphoma (NHL)United States
-
Dana-Farber Cancer InstitutePharmacyclics LLC.; The Leukemia and Lymphoma Society; Blood Cancer Research...Active, not recruitingLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
PfizerCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Malignant Melanoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Australia, Japan, France, Italy
-
Massachusetts General HospitalGenentech, Inc.WithdrawnKidney Insufficiency | Chronic Rejection
-
Massachusetts General HospitalGenentech, Inc.; BiogenWithdrawn
-
Genentech, Inc.CompletedMicroscopic Polyangiitis | Granulomatosis With PolyangiitisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Massachusetts General HospitalGenentech, Inc.CompletedSialadenitis | Retroperitoneal Fibrosis | Autoimmune Pancreatitis | Pseudotumor
-
University of Kansas Medical CenterCompletedNon-Hodgkins LymphomaUnited States
-
University of California, San FranciscoGenentech, Inc.CompletedInflammation | Rheumatoid Arthritis | Endothelial FunctionUnited States
-
Mayo ClinicGenentech, Inc.; Biogen; National Center for Research Resources (NCRR)TerminatedPrecancerous ConditionUnited States
-
Gaylis, Norman B., M.D.Genentech, Inc.; Oklahoma Medical Research FoundationCompletedRheumatoid ArthritisUnited States
-
Merck Sharp & Dohme LLCTerminatedRheumatoid Arthritis
-
Gilead SciencesTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
CelgeneCompletedLymphoma | Leukemia, Lymphocytic, Chronic, B-CellUnited States, United Kingdom, Germany, France, Italy, Netherlands, Japan
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom